Press Releases

All Releases
AngioDynamics, Inc. [ANGO] to Ring The NASDAQ Stock Market Closing Bell
Jul 13, 2012
ADVISORY, July 13, 2012 (GLOBE NEWSWIRE) -- What: AngioDynamics [ANGO], a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, will visit the NASDAQ MarketSite in Times Square .
AngioDynamics Reports Fiscal 2012 Fourth Quarter and Full Year Financial Results
Jul 12, 2012
Net sales of $57.7 million with Navilyst Medical contributing $4.8 million GAAP net loss of $7.0 million , or $0.27 per share; adjusted (Non-GAAP) net income of $2.6 million , or $0.10 per share, including $0.01 from Navilyst Medical Integration of Navilyst Medical is progressing on schedule
AngioDynamics to Report Fiscal 2012 Fourth Quarter and Full Year Financial Results and Hold Conference Call on July 12, 2012
Jul 03, 2012
ALBANY, N.Y. , July 3, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report its fiscal 2012 fourth quarter and full year
Journal of the American College of Surgeons Publishes Study on Using the NanoKnife(R) System to Treat Liver Tumors Adjacent to Blood Vessels
Jul 02, 2012
ALBANY, N.Y. , July 2, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced the publication of a study in the Journal of the American College of
AngioDynamics Completes Acquisition of Navilyst Medical
May 22, 2012
ALBANY, N.Y. , May 22, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced it has completed its acquisition of Navilyst Medical .
AngioDynamics Appoints Experienced Industry Executive as Chief Technology Officer
May 21, 2012
ALBANY, N.Y. , May 21, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the appointment of George W.
AngioDynamics Shareholders Approve Share Issuance for Navilyst Medical Acquisition
May 15, 2012
ALBANY, N.Y. , May 15, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the Company's shareholders approved the issuance of approximately
AngioDynamics Resumes NanoKnife(R) System Shipments in the U.S.
Apr 23, 2012
ALBANY, N.Y. , April 23, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the resumption of shipments of its NanoKnife ® System in
AngioDynamics Reports Fiscal 2012 Third Quarter Financial Results
Apr 04, 2012
ALBANY, N.Y. , April 4, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported financial results for the fiscal 2012 third quarter and nine
NanoKnife® System Clinical Experience Featured at Society of Surgical Oncology Conference
Apr 02, 2012
ALBANY, N.Y. --(BUSINESS WIRE)-- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced presentations on NanoKnife ® System clinical experience were given at the
Five Oral Presentations on Clinical Experience With NanoKnife® System Featured at Society of Interventional Radiology Conference
Mar 29, 2012
ALBANY, N.Y. --(BUSINESS WIRE)-- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced oral presentations on NanoKnife ® System clinical experience took place at the
AngioDynamics Establishes Strategic Relationship with Microsulis Medical Ltd.
Mar 26, 2012
Exclusive International Distribution Rights for Leading Microwave Ablation Products Equity Investment with Exclusive Option to Purchase Technology ALBANY, N.Y. & DENMEAD, England --(BUSINESS WIRE)-- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices
AngioDynamics to Report Fiscal 2012 Third Quarter Financial Results and Hold Conference Call on April 4, 2012
Mar 21, 2012
ALBANY, N.Y. , March 21, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report its fiscal 2012 third quarter financial
AngioDynamics to Present at Upcoming Investor Conferences
Feb 21, 2012
ALBANY, N.Y. , Feb. 21, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo , President and Chief Executive Officer,
AngioDynamics Receives FDA Clearance for NeverTouch Direct(TM) Procedure Kit to be Used With the VenaCure EVLT(R) System
Feb 14, 2012

NeverTouch Direct Kit Allows Physicians to Treat Varicose Veins With Fewer Procedure Steps

AngioDynamics Launches DuraFlow(TM) 2 Chronic Hemodialysis Catheter
Feb 08, 2012

New Offering Provides Additional Configurations, and Convenient Packaging for Inventory Control and Out-Patient Settings

AngioDynamics to Acquire Navilyst Medical for $372 Million
Jan 31, 2012
AngioDynamics to host conference call today at 11:30 am ET Increases Scale in Vascular Access and Peripheral Vascular Markets Expands Product Portfolio and Adds Innovative Technologies Strengthens Focus on Operational Excellence Expected to be Accretive in FY13 ALBANY, N.Y. and MARLBOROUGH, Mass.
AngioDynamics Updates Financial Guidance for Fiscal Year 2012
Jan 24, 2012
Company Implements Voluntary Recall of Ablation Zone Estimator Software on NanoKnife ® Systems Installed in the U.S. Resumption of NeverTouch ® Procedure Kit Shipments Leads to Better Than Expected Demand ALBANY, N.Y. , Jan. 24, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a
AngioDynamics to Present at the 30th Annual J.P. Morgan Healthcare Conference on January 12, 2012
Jan 06, 2012
ALBANY, N.Y. , Jan. 6, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the 30th Annual J.P.
AngioDynamics Reports Fiscal 2012 Second Quarter Financial Results
Jan 05, 2012
ALBANY, N.Y. , Jan. 5, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported financial results for the fiscal 2012 second quarter ended
Displaying 161 - 180 of 615

Copyright Nasdaq. Minimum 15 minutes delayed.